Jpmorgan Chase & CO Innoviva, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Innoviva, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 506,204 shares of INVA stock, worth $9.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

506,204

Previous 137,359 268.53%

Holding current value

$9.8 Million

Previous $2.09 Million 296.61%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$14.4 - $16.4 $5.31 Million - $6.05 Million	368,845 Added 268.53%	506,204 $8.3 Million
Q1 2024 May 10, 2024	SELL	$14.56 - $16.78 $2.79 Million - $3.22 Million	-191,848 Reduced 58.28%	137,359 $2.09 Million
Q4 2023 Feb 12, 2024	BUY	$12.32 - $16.27 $110,953 - $146,527	9,006 Added 2.81%	329,207 $5.28 Million
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $24,418 - $27,418	-1,974 Reduced 0.61%	320,201 $4.16 Million
Q2 2023 Aug 11, 2023	BUY	$11.39 - $13.72 $253,336 - $305,160	22,242 Added 7.42%	322,175 $4.1 Million
Q1 2023 May 18, 2023	BUY	$10.73 - $13.6 $850,159 - $1.08 Million	79,232 Added 35.9%	299,933 $3.37 Million
Q1 2023 May 11, 2023	SELL	$10.73 - $13.6 $1.23 Million - $1.56 Million	-114,875 Reduced 34.23%	220,701 $2.48 Million
Q4 2022 Feb 13, 2023	BUY	$11.8 - $13.78 $312,912 - $365,418	26,518 Added 8.58%	335,576 $4.45 Million
Q3 2022 Nov 14, 2022	SELL	$11.61 - $15.22 $788,806 - $1.03 Million	-67,942 Reduced 18.02%	309,058 $3.59 Million
Q2 2022 Aug 11, 2022	BUY	$14.32 - $19.88 $1.01 Million - $1.4 Million	70,203 Added 22.88%	377,000 $5.56 Million
Q1 2022 May 11, 2022	BUY	$15.39 - $20.25 $418,315 - $550,415	27,181 Added 9.72%	306,797 $5.94 Million
Q4 2021 Feb 10, 2022	BUY	$15.91 - $18.72 $607,077 - $714,299	38,157 Added 15.8%	279,616 $4.82 Million
Q3 2021 Nov 12, 2021	BUY	$13.06 - $17.24 $3.15 Million - $4.16 Million	241,459 New	241,459 $4.04 Million

Others Institutions Holding INVA

# of Institutions

221

Shares Held

79.1M

Call Options Held

20K

Put Options Held

5.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.35B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Innoviva, Inc. Transaction History